Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
COVID-19 Vaccine (Vero Cell) ,Inactivated
BIOLOGICAL
2 trials
Sponsors
CNBG-Virogin Biotech (Shanghai) Ltd.
Conditions
SARS-CoV-2 Infection
Phase 1
A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine
NCT06113744
CNBG-Virogin Biotech (Shanghai) Ltd.
SARS-CoV-2 Infection
Start: 2023-03-10
End: 2024-06-30
Target: 164
Updated: 2023-11-08
Phase 2
A PhaseⅡ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine
NCT06113731
CNBG-Virogin Biotech (Shanghai) Ltd.
SARS-CoV-2 Infection
Start: 2023-07-10
End: 2024-10-31
Target: 980
Updated: 2023-11-08